Startups.Bio showcases an emerging biotech startup each week, selected by the analyst team at VentureRadar from the 10,000s of companies we track.
We featured 10 biotech startups on Startups.Bio during the final quarter of 2020. Below is the full list. You can also head over to the VentureRadar Database to find 1000s of similar companies. Ambagon Therapeutics aims to develop first in class protein-protein interaction stabilizer drugs as novel targeted cancer treatments. Ambagon says its approach opens […]
View post to subscribe to site newsletter.
Ambagon Therapeutics aims to develop first in class protein-protein interaction stabilizer drugs as novel targeted cancer treatments. Ambagon says its approach opens up novel target space as well as having an innovative mechanism of action. Protein–protein interactions (PPIs) are one of the core processes by which cells function and interact with their environment, making them […]
View post to subscribe to site newsletter.
Founded by a team of researchers from Harvard University, i2O Therapeutics is developing a platform to enable oral delivery of traditionally injectable biological drugs, such as peptides and proteins. The company’s platform enables drugs that traditionally would not survive the hostile environment of the digestive system to pass through safely by utilizing a unique coating […]
View post to subscribe to site newsletter.